Advertisement
Research Article| Volume 58, ISSUE 9, P1158-1163, November 2020

Download started.

Ok

Comparison of the eighth edition of the TNM and Brigham Women’s Hospital staging systems for cutaneous squamous cell carcinoma of the head and neck: a six-year review

  • C.M. Bowe
    Correspondence
    Corresponding author at: Oral & Maxillofacial Surgery Department, St Richards Hospital, Western Sussex Hospitals Foundation Trust, Chichester, Western Sussex, PO19 6SE. Fax: +44 01243 831544.
    Affiliations
    Oral & Maxillofacial Surgery Department, St. Richards Hospital, Chichester, Western Sussex Hospitals Foundation Trust
    Search for articles by this author
  • S. Houlton
    Affiliations
    Oral & Maxillofacial Surgery Department, St. Richards Hospital, Chichester, Western Sussex Hospitals Foundation Trust
    Search for articles by this author
  • S. Walsh
    Affiliations
    Oral & Maxillofacial Surgery Department, St. Richards Hospital, Chichester, Western Sussex Hospitals Foundation Trust
    Search for articles by this author
Published:October 16, 2020DOI:https://doi.org/10.1016/j.bjoms.2020.08.028

      Abstract

      This study was undertaken with the aim to compare the T stages in a series of cutaneous squamous cell carcinoma (cSCC) patients using both the eighth edition of the Union for International Cancer Control (UICC) TNM Classification of Malignant Tumours (TNM8) and Brigham and Women’s Hospital (BWH) staging systems. This would allow comparison of the two to determine suitability with regards to T stage and the effect on local recurrence and nodal disease. This was a six-year retrospective cohort study of patients with primary invasive cSCC of the head and neck who were diagnosed and treated at Western Sussex Hospitals Trust in the United Kingdom between 2007 and 2012. The TNM8 and BWH staging systems were applied to these primary cSCCs. A total of 695 invasive cSCCs treated in 604 patients over six years were identified. Most patients were male (76%), with a mean (range) age of 81 (50-103) years. The most common location for local recurrence was the scalp (n = 26, 58%). Regional metastasis occurred most commonly in the parotid gland (n = 20, 63%). All tumours were classified using both staging systems. Specifically, 432 tumours remained in the same T stage (61%), and 192 were downstaged (27%) and 71 upstaged using the BWH (10%). The median (SD) follow-up time was 23 (28) months (range 1-123). The BWH alternative staging system overlapped with the TNM8 in high-stage and low-stage tumour assignment. The highest percentage of local recurrence and regional metastasis occurred in T2b tumours.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. The British Association of Dermatology. Available from URL: http://www.bad.org.uk (last accessed 20 August 2020).

        • Motley R.
        • Kersey P.
        • Lawrence C.
        • et al.
        Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma.
        Br J Dermatol. 2002; 146: 18-25
        • Jambusaria-Pahlajani A.
        • Miller C.J.
        • Quon H.
        • et al.
        Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes.
        Dermatol Surg. 2009; 35: 574-585
        • Alam M.
        • Ratner D.
        Cutaneous squamous-cell carcinoma.
        N Engl J Med. 2001; 344: 975-983
        • Breuninger H.
        • Black B.
        • Rassner G.
        Microstaging of squamous cell carcinomas.
        Am J Clin Pathol. 1990; 94: 624-627
        • Keohane S.G.
        • Proby C.M.
        • Newlands C.
        • et al.
        The new 8th edition of TNM staging and its implications for skin cancer: a review by the British Association of Dermatologists and the Royal College of Pathologists, U.K.
        Br J Dermatol. 2018; 179: 824-828
        • Clark J.R.
        • Rumcheva P.
        • Veness M.J.
        Analysis and comparison of the 7th edition American Joint Committee on Cancer (AJCC) nodal staging system for metastatic cutaneous squamous cell carcinoma of the head and neck.
        Ann Surg Oncol. 2012; 19: 4252-4258
      2. Amin M.B. Gress D.M. Meyer Vega L.R. AJCC cancer staging manual. eighth edition. Springer, 2017
      3. Edge S.B. Byrd D.R. Compton C.C. AJCC cancer staging manual. seventh edition. Springer, 2009
        • Karia P.S.
        • Jambusaria-Pahlajani A.
        • Harrington D.P.
        • et al.
        Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women’s Hospital tumor staging for cutaneous squamous cell carcinoma.
        J Clin Oncol. 2014; 32: 327-334
        • Cañueto J.
        • Burguillo J.
        • Moyano-Bueno D.
        • et al.
        Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women’s Hospital alternative staging system for cutaneous squamous cell carcinoma: implications for clinical practice.
        J Am Acad Dermatol. 2019; 80 (106–13.e2)
        • Karia P.S.
        • Morgan F.C.
        • Califano J.A.
        • et al.
        Comparison of tumor classifications for cutaneous squamous cell carcinoma of the head and neck in the 7th vs 8th edition of the AJCC Cancer Staging Manual.
        JAMA Dermatol. 2018; 154: 175-181
        • Burton K.A.
        • Ashack K.A.
        • Khachemoune A.
        Cutaneoussquamous cell carcinoma: a review of high-risk and metastatic disease.
        Am J Clin Dermatol. 2016; 17: 491-508
        • Morton D.L.
        • Thompson J.F.
        • Cochran A.J.
        • et al.
        Final trial report of sentinel-node biopsy versus nodal observation in melanoma.
        N Engl J Med. 2014; 370: 599-609
        • Dinehart S.M.
        • Peterson S.
        Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system.
        Dermatol Surg. 2005; 31: 1379-1384
        • Farasat S.
        • Yu S.S.
        • Neel V.A.
        • et al.
        A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumour (T) characteristics.
        J Am Acad Dermatol. 2011; 64: 1051-1059